The past two months have seen the Chinese government issue many updates for the medical technology industry, in both summaries of technical guidance and China unique standards; and in changes to the medical device review process.
These high-level updates include the National Medical Products Administration’s (NMPA, formerly the CFDA) release of four registration technical review guidelines;...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?